Citation 89104

TADA,Y: SHIKISHIMA,Y: TAKAISHI,Y: SHIBATA,H: HIGUTI,T: HONDA,G: ITO,M: TAKEDA,Y: KODZHIMATOV,OK: ASHURMETOV,O: OHMOTO,Y:. (2002). COUMARINS AND GAMMA-PYRONE DERIVATIVES FROM PRANGOS PABULARIA: ANTIBACTERIAL ACTIVITY AND INHIBITION OF CYTOKINE RELEASE.. 59(6)

Citation Details

Title	COUMARINS AND GAMMA-PYRONE DERIVATIVES FROM PRANGOS PABULARIA: ANTIBACTERIAL ACTIVITY AND INHIBITION OF CYTOKINE RELEASE.
Authors	TADA,Y: SHIKISHIMA,Y: TAKAISHI,Y: SHIBATA,H: HIGUTI,T: HONDA,G: ITO,M: TAKEDA,Y: KODZHIMATOV,OK: ASHURMETOV,O: OHMOTO,Y:
Year	2002
Volume	59
Issue	6

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (1)

Prangos pabularia (APIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	MALTOL-(6-O-ACETYL)-BETA-D-GLUCOPYRANOSIDE	None
3	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PABULARIN A	None
4	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PABULARIN B	None
5	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PABULARIN C	None
6	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PEUCEDANIN,OXY: HYDRATE	None
7	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY: HYDRATE	ACTIVE
8	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY: HYDRATE	INACTIVE
9	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY: HYDRATE	ACTIVE
10	TUMOR NECROSING FACTOR SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY: HYDRATE	ACTIVE
11	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PEUCEDANIN,OXY: METHANOLATE	None
12	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY: METHANOLATE	EQUIVOCAL
13	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY: METHANOLATE	INACTIVE
14	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY: METHANOLATE	EQUIVOCAL
15	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	IMPERATORIN,ISO:	None
16	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PEUCEDANIN,OXY:	None
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY:	EQUIVOCAL
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY:	INACTIVE
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY:	INACTIVE
20	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY:	ACTIVE
21	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY:	WEAK ACTIVITY
22	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY:	WEAK ACTIVITY
23	TUMOR NECROSING FACTOR SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PEUCEDANIN,OXY:	ACTIVE
24	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PEUCEDANIN,OXY: HYDRATE-2'-O-MONOACETATE	None
25	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PEUCEDANIN,OXY: HYDRATE-3'-O-BETA-D-GLUCOPYRANOSIDE	None
26	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HERACLENOL	None
27	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERACLENOL	INACTIVE
28	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERACLENOL	WEAK ACTIVITY
29	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERACLENOL	WEAK ACTIVITY
30	TUMOR NECROSING FACTOR SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERACLENOL	ACTIVE
31	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HERACLENOL-3'-METHYL ETHER	None
32	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERACLENOL-3'-METHYL ETHER	ACTIVE
33	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERACLENOL-3'-METHYL ETHER	INACTIVE
34	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERACLENOL-3'-METHYL ETHER	WEAK ACTIVITY
35	TUMOR NECROSING FACTOR SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERACLENOL-3'-METHYL ETHER	ACTIVE
36	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	IMPERATORIN	None
37	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	IMPERATORIN	EQUIVOCAL
38	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	IMPERATORIN	INACTIVE
39	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	IMPERATORIN	EQUIVOCAL
40	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	IMPERATORIN	ACTIVE
41	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	IMPERATORIN	ACTIVE
42	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	IMPERATORIN	ACTIVE
43	TUMOR NECROSING FACTOR SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	IMPERATORIN	ACTIVE
44	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	GOSPHEROL,ISO:	None
45	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GOSPHEROL,ISO:	ACTIVE
46	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GOSPHEROL,ISO:	WEAK ACTIVITY
47	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GOSPHEROL,ISO:	ACTIVE
48	TUMOR NECROSING FACTOR SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GOSPHEROL,ISO:	ACTIVE
49	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HERACLENOL-3'-O-BETA-D-GLUCOPYRANOSIDE	None
50	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ULOPTEROL	None
51	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ULOPTEROL	WEAK ACTIVITY
52	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ULOPTEROL	ACTIVE
53	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ULOPTEROL	INACTIVE
54	TUMOR NECROSING FACTOR SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ULOPTEROL	ACTIVE
55	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TAMARIN	None
56	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TAMARIN	WEAK ACTIVITY
57	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TAMARIN	ACTIVE
58	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TAMARIN	INACTIVE
59	TUMOR NECROSING FACTOR SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TAMARIN	ACTIVE
60	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	AURAPTENOL	None
61	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	OSTHOL	None
62	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OSTHOL	WEAK ACTIVITY
63	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OSTHOL	INACTIVE
64	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OSTHOL	WEAK ACTIVITY
65	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OSTHOL	ACTIVE
66	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OSTHOL	ACTIVE
67	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OSTHOL	ACTIVE
68	TUMOR NECROSING FACTOR SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OSTHOL	ACTIVE
69	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PANICULAL	None
70	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	MAJURIN	None
71	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MAJURIN	INACTIVE
72	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MAJURIN	INACTIVE
73	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MAJURIN	INACTIVE
74	TUMOR NECROSING FACTOR SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MAJURIN	ACTIVE
75	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RIVULOBIRIN E	None
76	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	LOLIOLIDE	None
77	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BENZYL ALCOHOL,2-3-4-TRIMETHYL: O-BETA-D-GLUCOPYRANOSIDE	None
78	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CYCLOHEXA-2-5-DIEN-4-ONE,1-1-5-TRIMETHYL-2-HYDROXY-METHYL: O-BETA-D-GLUCOPYRANOSIDE	None
79	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CYCLOHEX-5-ENE-4-ONE,1-1-5-TRIMETHYL-2-HYDROXY-METHYL: O-BETA-D-GLUCOPYRANOSIDE	None
80	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOHEX-5-ENE-4-ONE,1-1-5-TRIMETHYL-2-HYDROXY-METHYL: O-BETA-D-GLUCOPYRANOSIDE	ACTIVE
81	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOHEX-5-ENE-4-ONE,1-1-5-TRIMETHYL-2-HYDROXY-METHYL: O-BETA-D-GLUCOPYRANOSIDE	WEAK ACTIVITY
82	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOHEX-5-ENE-4-ONE,1-1-5-TRIMETHYL-2-HYDROXY-METHYL: O-BETA-D-GLUCOPYRANOSIDE	ACTIVE
83	TUMOR NECROSING FACTOR SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOHEX-5-ENE-4-ONE,1-1-5-TRIMETHYL-2-HYDROXY-METHYL: O-BETA-D-GLUCOPYRANOSIDE	WEAK ACTIVITY
84	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SPATHULENOL	None
85	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAURANOL	None
86	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	DAUCOSTEROL	None
87	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PROPYL,ISO: 1-O-BETA-D-GLUCOPYRANOSIDE	None
88	INTERLEUKIN-2 FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROPYL,ISO: 1-O-BETA-D-GLUCOPYRANOSIDE	ACTIVE
89	INTERLEUKIN-4 RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROPYL,ISO: 1-O-BETA-D-GLUCOPYRANOSIDE	ACTIVE
90	INTERLEUKIN-1-BETA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROPYL,ISO: 1-O-BETA-D-GLUCOPYRANOSIDE	ACTIVE
91	TUMOR NECROSING FACTOR SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROPYL,ISO: 1-O-BETA-D-GLUCOPYRANOSIDE	ACTIVE

Citation 89104

Citation Details

Summary

Organisms and Their Experiments (1)

Prangos pabularia (APIACEAE)

Show SPARQL Queries (1)

Query 1